APA (7th ed.) Citation

CJ, G., SA, L., SE, G., JL, G., M, D., TM, B., . . . KC, H. (2026). Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes. Diabetes, 75(3), 506. https://doi.org/10.2337/db25-0777

Chicago Style (17th ed.) Citation

CJ, Greenbaum, et al. "Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes." Diabetes 75, no. 3 (2026): 506. https://doi.org/10.2337/db25-0777.

MLA (9th ed.) Citation

CJ, Greenbaum, et al. "Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes." Diabetes, vol. 75, no. 3, 2026, p. 506, https://doi.org/10.2337/db25-0777.